slides · global inventory
Complication
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 25,056
Current window 17,191-17,220
Pages 836
Rows per page 30
Beat
17,191-17,220 of 25,056
07
arm | IPO Presentation Deck | 117 slidesarm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank Beat · Problem1 hit
08
arm | IPO Presentation Deck | 117 slidesarm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank Beat · Problem1 hit
09
This appears to be a title or transition slide with no text content.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank Beat · Problem1 hit
10
The slide uses a high-tech, abstract background with digital noise/glitch effects.arm | IPO Presentation Deck | 117 slides · Arm
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
06
The chart uses a line graph to show operating income over time, annotated with specific park attraction launches and a callout box comparing investment vs income growth.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Interest1 hit
07
The chart uses a waterfall bridge to decompose the growth drivers.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Interest1 hit
08
The slide uses a split-screen layout to contrast IP portfolio strength with financial performance.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Interest1 hit
09
The slide uses a chevron-like background shape to emphasize the forward-looking nature of the investment.Disney | Investor Presentation Deck | 27 slides · Disney
Conference presentation Investor relations Beat · Interest1 hit
06
Uses a value-chain style diagram to show the complexity of the current manual process.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
07
The slide uses a map-based hub-and-spoke visual to connect specific industry pain points to the global supply chain.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
09
Genius Group | Investor Presentation Deck | 29 slidesGenius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
GMS | Investor Conference Presentation Deck | 26 slidesGMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations Beat · Problem1 hit
04
The chart uses imagery within the donut segments to represent the two sectors.GMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations Beat · ProblemLoop · Mece Breakdown1 hit
05
GMS | Investor Conference Presentation Deck | 26 slidesGMS | Investor Conference Presentation Deck | 26 slides · GMS
Conference presentation Investor relations Beat · ProblemLoop · Voice Of Customer1 hit
03
Hipgnosis Songs Fund | Results Presentation Deck | 22 slidesHipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Problem (Identify pain)1 hit
04
Hipgnosis Songs Fund | Results Presentation Deck | 22 slidesHipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Problem (Identify pain)1 hit
17
Hipgnosis Songs Fund | Results Presentation Deck | 22 slidesHipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Interest1 hit
18
Hipgnosis Songs Fund | Results Presentation Deck | 22 slidesHipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Interest1 hit
03
This is a classic 'problem-solution' framing slide.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide uses a hub-and-spoke diagram to illustrate the central problem of CAR-T neurotoxicity and its four primary negative outcomes.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
05
Includes a cartoon mascot at the bottom.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
06
The slide uses a visual comparison to highlight the safety advantage of NXC-201, specifically focusing on neurotoxicity and CRS duration.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
07
Uses a visual icon-grid to represent market expansion from 5% of hospitals to a much broader network.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
08
The slide uses a molecular biology diagram to illustrate the structural difference in the binding domain of the NXC-201 therapy compared to competitors.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
09
Includes comparative bar charts and flow cytometry data.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · InterestLoop · Aha Moment1 hit
10
The slide uses a comparative timeline/chart layout to contrast clinical outcomes of three different therapies.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · InterestLoop · Aha Moment1 hit
11
The chart demonstrates the efficacy of NXC-201 (formerly HBI0101) in clearing diseased cells.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
12
The slide uses a process flow diagram to connect cellular pathology to clinical symptoms in the heart, liver, and kidneys.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
13
Includes extensive source citations in the footer.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
14
The slide uses a table structure to contrast treatment outcomes and patient growth across three stages of multiple myeloma.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit